What You Should Know:
– LinusBio, a leader in precision exposome medicine, and Coralis Health, a pioneering virtual care platform for neurodivergent children and families, today announced a partnership to provide comprehensive, end-to-end diagnostic services for autism spectrum disorder (ASD).
– The collaboration combines LinusBio’s breakthrough ClearStrand-ASD™ biomarker test with Coralis Health’s specialized care platform, creating a seamless pathway from early screening to diagnosis and intervention.
Streamlining the Path from Screening to Intervention
Evidence shows that early diagnosis and intervention are crucial for improved outcomes, yet many families face lengthy delays in accessing diagnostic support. Currently, waitlists for diagnostic evaluations can be years long, delaying access to critical early interventions. This new partnership creates a direct bridge between biomarker screening and comprehensive virtual diagnostic services, significantly reducing the time between initial concern and professional evaluation.
Once ClearStrand-ASD results are available, LinusBio directly refers qualifying families to Coralis Health. Coralis Health’s virtual diagnostic teams reach out within five calendar days to schedule intake appointments and complete comprehensive evaluations within 90 days. The integrated service is designed for families who have concerns about their child’s development and are seeking both objective screening insights and expert diagnostic evaluation. Healthcare and service providers can also leverage this streamlined pathway to offer their patients a comprehensive diagnostic solution that reduces referral complexity and wait times.
Dr. Ayesha Cheema-Hasan, founder and CEO of Coralis Health, explained, “Our goal has always been to make sure that children are connected to life-changing therapies in a timely manner, while providing the highest quality care. We also want to reduce the burden on clinicians, by finding ways to standardize care in a space that’s currently too dependent on individual clinical expertise and training. By leveraging technology thoughtfully, we aim to bridge the gap in access, and ensure that every child has the opportunity to thrive regardless of where they start.”
